http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017070113-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c37107c09daec2eed852e153f55050c9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 2016-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51d781170958f445513c6d6c27e5cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b247671e140facebcb8dfb802c0edb
publicationDate 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017070113-A1
titleOfInvention Pharmaceutical composition comprising nanog shrna, and method of using nanog shrna to treat cancer
abstract The present description relates to an inhibitory RNA molecule, comprising an oligonucleotide that selectively knocks down expression a NANOG pseudogene expressed in many human cancers, a replicating viral vector capable of encoding such inhibitory RNA molecule, pharmaceutical compositions comprising said vector, and methods of treating cancer by administration of said pharmaceutical composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112941039-A
priorityDate 2015-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005042714-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770442-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005100576-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012078586-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5712136-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922315-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226466072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11457737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87073779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226466070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226466071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75235673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227736163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21486061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87073780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87073781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530361

Total number of triples: 68.